key: cord-0720177-wqtqsjcs
authors: Paterson, Catherine; Bacon, Rachel; Dwyer, Rebecca; Morrison, Kittani S.; Toohey, Kellie; O'Dea, Amy; Slade, James; Mortazavi, Reza; Roberts, Cara; Pranavan, Ganes; Cooney, Corrina; Nahon, Irmina; Hayes, Sandi
title: The role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer team: Implications for practice
date: 2020-10-15
journal: Semin Oncol Nurs
DOI: 10.1016/j.soncn.2020.151090
sha: 4e5832fea2b7a128d70b3880f3a48e808a609295
doc_id: 720177
cord_uid: wqtqsjcs

OBJECTIVE: This literature review aims to explore the role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer care team. DATA SOURCES: Electronic databases including CINAHL, MEDLINE, PsychINFO, Scopus, and grey literature were searched using Google Scholar up until September 2020. CONCLUSION: While the safe and effective delivery of cancer care via telehealth requires education and training for healthcare professionals and patients, telehealth has provided a timely solution to the barriers caused by the COVID-19 pandemic on the delivery of interdisciplinary cancer services. Globally, evidence has shown that telehealth in cancer care can leverage an innovative response during the COVID-19 pandemic but may provide a long-lasting solution to enable patients to be treated appropriately in their home environment. Telehealth reduces the travel burden on patients for consultation, affords a timely solution to discuss distressing side effects, initiate interventions, and enable possible treatment additions and/or changes. IMPLICATIONS FOR NURSING PRACTICE: Global public health disasters pose significant and unique challenges to the provision of necessary services for people affected by cancer. Oncology nurses can provide a central contribution in the delivery of telehealth through transformational leadership across all domains and settings in cancer care. Oncology nurses provide the “hub of cancer care” safely embedded in the interdisciplinary team. Telehealth provides a solution to the current global health crisis but could also benefit the future provision of services and broad reach clinical trials.

Data from GLOBOCAN 2018 identified that there was 18.1 million new cancer incidences and 9.6 million cancer mortalities across the world in 2018. 1 It is estimated that 1 in 10 women and 1 in 8 men will be diagnosed with cancer during their lifetime. 1 Across 100 countries, cancer is ranked as the first or second cause of premature death. People with cancer may be immunosuppressed due to their disease and treatment and are therefore at greater risk for infections, such as coronavirus disease (COVID-19). 2 The novel COVID-19 was first identified in Wuhan, China in December 2019. 3 COVID-19 spread rapidly through human-human transmission and resulted in a pandemic affecting 216 countries across the globe. 3, 4 COVID-19 is a respiratory disease caused by a coronavirus called SARS-CoV-2 and as such the primary symptoms are fever, cough and shortness of breath. 5 Additionally, evidence now suggests that symptoms of sore throat, diarrhoea, headache, muscle or joint pain, fatigue and loss of sense of smell and taste are associated with mild cases of COVID-19. 6 As of the 17 th of September 2020, there has been over 29 million cases and nearly 931,321 deaths associated with COVID-19 globally, resulting in a fatality rate of approximately 3%. 4 Early evidence out of China highlighted that the fatality rate was higher for people with pre-existing comorbidities. 7 In particular, people with cancer were seen to have a mortality rate of 5.6%. 7 Further studies in Europe and America have supported these findings. [8] [9] [10] [11] Impact of COVID- 19 

Strategies such as social distancing and quarantine requirements have been implemented globally to mitigate and contain the spread of COVID-19. 8 These measures, as well as the distress associated with a pandemic, have resulted in widespread anxiety and a deterioration in mental health across the globe. 12 The level of distress cancer patients experience may be increased due to concerns about contracting COVID-19 and how the pandemic could affect their access to oncology services for care and treatment. 3 Social distancing measures including the limitation of visitors in healthcare facilities may also affect a cancer patient's support network and sense of well-being. 13 Telehealth and Cancer Care during Telehealth is defined by the Telehealth Resource Centre as a collection of means or methods for enhancing the healthcare, public health, and health education delivery and support using telecommunications technologies. 14, 15 Telehealth in cancer care is not new; it has been effectively used for cancer symptom management, survivorship care, providing remote chemotherapy supervision, palliative care, and psychological support. 2, 16, 17 Nonetheless, the social distancing and quarantine requirements instigated to reduce transmission of COVID-19 has led to an unprecedented, rapid and widespread adoption of telehealth technology. 15 As people affected by cancer are at a higher risk of mortality from COVID-19, it is critical that their risk of contracting COVID-19 is reduced. 16 The use of telehealth can aid this process by providing safe and appropriate care to the patient whilst minimising physical contact with a healthcare facility. 18 Therefore, the aim of this literature review is to explore how telehealth has been utilised across interdisciplinary healthcare professional groups in cancer care and broad reach clinical trials delivery.

The rapid deployment of telehealth services during COVID-19 has resulted in a paradigm shift, where digital by default has become the new norm for healthcare delivery. 19 It is postulated that these digital solutions have the potential to become a great equalizer, acting as a catalyst for change in populations impacted by social determinants of health. 20 However, the opportunities afforded by telehealth are only beneficial if the patient possesses the necessary skill set to effectively comprehend, navigate, and troubleshoot the required digital interfaces, otherwise there is a risk that health disparities will be further increased through the addition of a digital divide. 21 This specific skill set is known as telehealth literacy and is defined as the aptitude to find, comprehend, and evaluate health information from electronic sources and apply the knowledge gained to addressing or solving a health problem. 22 Telehealth literacy requires an interplay between six core literacies: traditional (reading and writing skills), information (how to locate and use relevant information), media (critical thinking and filtering trustworthy information), health (ability to appraise and act on health information), scientific (understand science based information) and computer (ability to use digital technology). 22 Empirical evidence has identified specific vulnerable patient groups to telehealth literacy challenges which include those who are older, live rurally, have less formal education, lower socioeconomic status, come from culturally and linguistically diverse backgrounds, living with multiple chronic conditions and those who have less access to online resources. 23 Low levels of telehealth literacy can have significant implications for online security, particularly with the sensitive nature of health information, the need to understand complex privacy laws and the volume of unregulated health apps currently available. [24] [25] [26] It has been observed that higher telehealth literacy levels empower cancer patients and caregivers to engage in shared decision making and has been linked to seeking a second opinion, effective utilization of self-monitoring/self-management strategies outside of the clinical setting, as well as increased treatment compliance throughout the cancer care continuum. 24, 27 Patient, caregiver, and practitioner education in telehealth systems is vital to build capacity and smooth the transition to online delivery. 24, 28 Oncology nurses and members of the interdisciplinary team should consider administering a patient reported outcome measure, such as the eHealth Literacy Scales (eHEALS) 29 to determine the eHealth literacy levels of patients. This should be delivered prior to the implementation of online interventions, thus ensuring patients and caregivers continue to experience quality person-centered cancer care. 30 Moreover, telehealth literacy skills are crucial for people affected by cancer and their caregivers, as they must be able to interpret the information to make informed decisions about different avenues of cancer care, and possible participation in clinical trials. 24, 30 

During the COVID-19 pandemic, radiation oncologists have followed guidelines that provide alternate treatment options. COVID-19 clinical guidelines 31 have enabled patients to delay treatment, come for fewer fractions of treatment (hypofractionation) or, to exclude radiotherapy completely. Such considerations are important when access is reduced or visiting the hospital setting creates additional risk to the patient. 31 For example, lung cancer patients have been given increased options for high dose stereotactic treatments to reduce visits to one to three sessions. Whereas prior to COVID-19, a more conservative approach (around 25 treatments) resulted in increased travel for treatments at an oncology centre. 31 Elsewhere, international breast cancer clinical guidelines recommend several different options to ensure that hospital visits are kept to a minimum, which include: increasing the scope for the use of moderate hypofractionation (15 fractions), increased utilisation of FAST forward trial fractionation (5 fractions) or omission of radiation treatment altogether for some specific cohorts. 32 In prostate cancer management guidelines created by a team of radiation oncologists from the United States (US) and United Kingdom (UK) recommend a combination of changes for different presenting stages of disease. Active surveillance is recommended for patients with low to favorable intermediate risk disease; whilst higher risk patients are managed with androgen depravation treatment until radiotherapy is safe to be delivered. Again, hypofractionation is recommended in most cases when treatment does commence. 33 In keeping with the changes in the delivery of cancer treatments there has been a rapid increase in the utilization of oncology telehealth service delivery.

Telehealth models were developed in Australia a decade ago to improve the care of oncology patients, particularly in rural Australia. 34 Until the COVID-19 pandemic, telehealth use in medical oncology was limited to rural patients and necessitated the presence of a general practitioner or nursing/allied health staff during the consultation. Despite the limited use, this model proved to be very successful and yielded high satisfaction among health care workers and rural oncology patients. 35 There is a dramatic change in this landscape since the current pandemic. Oncology practice all over Australia have now widely accepted and adopted to the telehealth model. Routine oncological reviews and the pre-chemotherapy assessments are now delivered through telehealth since the beginning of the pandemic (March 2020). This has significantly reduced the risk of exposure to the virus to immunocompromised patients by reducing the number of outpatient visits.

There are studies supporting the benefit of telehealth in minimizing the risk of COVID-19 transmission among patients and healthcare workers. 36 Careful clinical history and inspection through a video assisted platforms have enabled clinicians to assess cancer related symptoms and toxicities of chemotherapy. Telehealth has provided many advantages to the patients and carers along with the healthcare workers. The recent change to telehealth has reduced the need to travel to the hospital, which is a major advantage for the cancer patients who have mobility issues and/or other physical disabilities. Telehealth has improved access to home based palliative care services for many patients. Recent studies indicate that telehealth can be safely used in discussing the advanced directives with patients/carers while optimizing end of life care both at patient's home and at health care facilities. 37 The visual features of telehealth are helpful in establishing rapport with the health teams and close connectedness with the treating team. This model may also be utilized to help maintain the patient's of quality of life and reduce the carer stress. 37

During the COVID-19 pandemic, oncology specialists have been required to alter methods of service delivery across the clinic and treatment areas. Telehealth implementation has been facilitated by swift policy changes from the Medicare Benefits Scheme to enable physicians to provide telehealth to vulnerable patients from the 13 th of March 2020. Noteworthy, the previous telehealth Medicare codes had specific requirements which involved remote locations only, however, the new COVID-19 telehealth codes are now accessed by GP's, specialists, nurse practitioners, midwives and allied healthcare professionals for any consult where it was deemed clinically safe and appropriate.

Furthermore, the COVID-19 telehealth model in Australia has also supported phone consultations with patients whereas previously, there were tight restrictions on video consults only. 38

Many cancer centres have gone onto virtual cancer multidisciplinary team (MDT) meetings using various platforms including Microsoft Teams to ensure socially distant meetings. 39 This pragmatic approach has been welcomed by all health disciplines to ensure that multidisciplinary cancer team discussions continue to occur in a timely and safe approach during the COVID-19 pandemic 40 This platform has allowed specialized clinicians and teams to access meetings remotely, having a presence in meetings they may not have had access to prior to the pandemic, providing high quality advice to teams and care to patients. It is important for healthcare organisations to ensure that such platforms are safe and secure in keeping with data protection legislation. Given the success of the virtual MDTs meetings, it is likely that they will continue even after the end of the current pandemic because attendance of healthcare professionals at MDT meetings has increased compared to previous face-to-face MDTs meetings.

The COVID-19 pandemic has resulted in a shortage of accredited health placements due to social distancing, risk mitigation and isolation measures identified by placement partners. 41 At the same time, there has been a growth in telehealth technologies, funding and services. 38 While there is some research supporting the use of telehealth placements within accredited health programs which includes medicine, nursing and allied health, 42-44 the efficacy of telehealth for professional placements is underexplored.

Evidence to date indicates that telehealth can deliver high quality healthcare; 36 transcends geographical, architectural and physical distancing restrictions; 2 and offers potential financial, access, monitoring and in-home advantages. 16 Telehealth's functionality, to bring together expert clinicians and carers (even if geographically dispersed), facilitates interprofessional collaboration which is known to improve clinical performance, patient outcomes and patient satisfaction. 45 Interprofessional education (IPE) involves students from different professions learning with, from and about each other supporting the development of interprofessional learning competencies. 46 While some systematic reviews have been conducted to date examining the benefits of IPE in health education, 47 none have been conducted looking specifically at IPE through telehealth platforms.

Telehealth has the benefit of being able to be delivered remotely, ensuring a safe learning environment for students and for vulnerable members of the population, such as oncology patients, during COVID-19. 48 Moving forward, the demand for qualified health professionals with competencies in the use of telehealth, such as the use of technology, digital literacy and communication skills 41 is expected to rise. 48 Therefore, curriculum development in undergraduate and postgraduate healthcare professional accredited courses which embeds telehealth competencies should follow.

The rapid growth of digital technologies in 1990s was associated with an increasing use of computational imaging techniques in diagnostic pathology, although with many technical challenges. 49 The introduction of high-resolution digital cameras and the improvement of computational processing in the following years led to a better image quality and ease of access and brought about opportunities to help simulate actual microscopic examinations. 50, 51 These advancements consequently led to more sophisticated technologies which allowed for the whole slide imaging (WSI) of stained pathology glass slides in the clinical laboratory, to be viewed on the spot, sent to colleagues at distant places (telepathology), securely archived, or used for educational and research purposes. 52 Digital pathology encompasses WSI and related technologies such as image management system, laboratory information system, digital transcription, digital dashboard, work flow management, specimen labelling, tracking systems, digital image interpretation, and reporting tools. 52 There are many applications for digital pathology some of which are briefly mentioned here:

Primary diagnosis: scanned images of pathology slides can be sent to the laboratory information system and hospital information system, to be examined by the pathologist. 53 This is gradually becoming a standard practice, but different health care systems and labs vary in the extent to which they embrace this technology, from laboratories which have digitised a select histopathology subspecialty to the laboratories with a large-scale digitisation of whole pathology slides. 54 2.

Receiving/ giving second opinions and information sharing between pathologists: Digital and telepathology can facilitate obtaining second expert opinion on previously examined pathology slides from another on-site or off-site pathologists. 55 This approach is particularly useful for difficult cases. 56 3.

Remote or flexible working conditions: with situations such as the COVID-19 pandemic affecting the individuals' availability or mobility to and from the workplace, or even for the sake of flexible working situations, digital pathology provides an ideal platform where digital images of pathology slides can be electronically transferred to the pathologists far from their original labs (e.g. at their home office or even when they are away on a trip). 55, 57 Telepathology, can also be applied to improve the provision of pathology services to low-and middle-income countries 58 , or even rural and remote areas in high-income countries which are facing challenges in accessing pathology services which are mostly concentrated in large cities. 52 Another benefit of digital pathology and telepathology is that the pathologist can view and examine digital slides on their computer, laptop or even mobile phones, using a WiFi internet, mobile internet, or a "virtual private network" (VPN)

connection. 59 

A more effective workflow: Digitisation of the workflow in the pathology laboratory has been indicated to be able to accelerate the turnaround times of pathology diagnoses. 60 For example, the Kalmar and Linkӧping Hospitals in Sweden have efficiently integrated their slide scanners to their laboratory workflow allocation, and their pathologists regularly receive digital slides for making primary diagnoses without much need for waiting for the glass slides to arrive. 55 

Improved slide archiving and slide retrieval: Maintaining a digital slide archiving system makes the tedious task of slide retrieval more efficient and time-saving compared to the glass slides kept at storage cabinets.

Education: Digital and telepathology are increasingly used for educational purposes around the world and are gaining more acceptance among pathologists and academics. 59, 61 In Australia, a multi-university digital imaging online repository platform (partly related to human pathology) were launched in 2012. As of September 2020, this online platform contains over 20,600 medical and microscopic images which are being used for educational purposes at Australian and international universities. 62 The availability of archived high quality digital images is contributing to quality education at universities around the world. 55, 56 7. Improved ergonomic situations for pathologists: The use of digital pathology can improve the ergonomics of pathology slide examination, and in fact, many pathologists believe that it increases the efficiency of their work due to more comfortable working positions. 60, 63 8.

Research: WSI and digital pathology is increasingly used in clinical and collaborative research. Facilitated availability and same-time access to digital images by different researchers, will encourage collaborative intra-and inter-institutional research through sharing and pooling the digital images and the relevant information. 55 Having mentioned all the above, however, digital pathology and telehealth is in its developmental stages and there are several challenges ahead which should be overcome before the full digitisation of pathology imaging. Some of these challenges include the high cost of equipment as well as a need for standardisation of reporting systems 61 , standardisation of slide preparation and staining to prevent excessive variations in the slide quality 53, 56 , and computational complexities in the image analysis. 56

Internationally physiotherapists have incorporated telehealth practices for people affected by cancer to maintain services and contact without compromising their health. Using virtual communication methods, telehealth supports remote access to care for musculoskeletal assessments while maintaining social distancing. 64 Physiotherapists are an important member of the multidisciplinary team to help optimize function, movement, and quality of life for people affected by cancer. 65 Physiotherapy using telerehabilitation instead of conventional face-to-face care could be a lasting alternative to treat people diagnosed with cancer in their home environment after hospital discharge, but additional research is needed. 66

Details of studies evaluating broad-reach delivery of lifestyle (including physical activity, diet and weight change) interventions that sought to improve health outcomes in those with cancer were first published in 2002. Specifically, these included a randomised controlled trial (RCT) that evaluated the effect of a telephone-delivered high-vegetable, low-fat diet on breast cancer events and death in women with early stage breast cancer (n=3088). 67 The other pilot, RCT 68 evaluated a telephonedelivered weight-loss intervention for obese women with breast cancer (n=48). Within 10 years since the publication of results from these trials, an exponential rise in the number of studies evaluating the effect of broad-reach lifestyle interventions for people with cancer was observed. This increase was likely due to the growing recognition of (i) the clear association between physical activity and weight, and survival outcomes following cancer 69 , (ii) the growing evidence-base that supports lifestyle intervention (i.e., physical activity, exercise, weight loss and/or dietary intervention) leads to improvements in a range of health outcomes during and following treatment 70, 71 , and (iii) that face-to-face delivery of lifestyle interventions in clinical settings restricts access to a select group of oncology patients.

In Effect sizes reported in the studies included within the systematic review ranged from small (0.2-0.49) to large (>0.8). These review findings were similar to those reported following a review of nonbroad-reach intervention trials (i.e., including highly supervised, clinic-based trials) involving those with cancer 73,74 , as well as telephone-delivered lifestyle interventions in the general population. 72, 75 Further, one of the studies included in the review was a comparative-effectiveness trial, which demonstrated that a telephone-delivered 8-month exercise intervention was as effective for achieving improvements in fitness and quality of life, compared with the delivery of the same intervention face-to-face. 76 These findings, which include a preponderance of support for telephone-delivered interventions among cancer survivors, are particularly noteworthy since anecdotally there has been a reluctance by members of the cancer care team (including allied health professionals) to accept that broad-reach lifestyle intervention delivery can be safe, feasible and effective. Additionally, at least prior to COVID-19, funding models rarely allowed for telephone delivery of lifestyle advice and support. It seems that a virus pandemic rather than scientific evidence was needed to facilitate flexibility in the manner by which cancer care is and can be delivered.

With growing use of telehealth, it becomes particularly pertinent to highlight the limitations to the socioeconomic status -low through to high, residing in urban and more regional/rural areas, and with the majority of participants reporting more than one other comorbidity). Preliminary findings from the ongoing ECHO trial also demonstrate that telehealth delivery of exercise during chemotherapy for newly diagnosed ovarian cancer is safe and feasible. 78 Of note, as a direct consequence of the telehealth mode of delivery, unlike the vast majority of lifestyle intervention trials, ECHO was able to continue even during the strictest COVID19 restrictions. We now await the results that will determine whether the intervention is also cost-effective at improving survival, quality of life and function.

There is a strong body of evidence to support exercise therapy as part of standard care for people affected by cancer. 79 Regular exercise has been shown to have a positive effect on reducing adverse treatment side effects, enhancing mental wellbeing, and improving cancer survival rates. 79 The COVID-19 pandemic poses a significant risk to people with cancer 10 and most face-to-face exercise oncology services have ceased and have been modified to home-based or telehealth delivery to reduce the risk of infection, posing a risk of a reduction in uptake of these vital services. 80 It remains imperative for people diagnosed with cancer to engage in physical activity during these challenging times, particularly as the negative physical and mental health impacts of self-isolation and quarantine are becoming apparent. 81 The need for safer options for the delivery of exercise services for people affected by cancer has recently become desirable, with the current COVID-19 pandemic forcing clinicians to re-think how they can safely deliver exercise interventions. Telehealth is one such option which has not traditionally been the main format of exercise delivery for people affected by cancer. 80 However some studies have already demonstrated its' feasibility 75, 82 and effectiveness in improving physical 75 

The use of telehealth in the oncology setting is not new and in recent years has mainly been used to facilitate medical access for those individuals living in remote and rural areas. 28 During the early stages of the COVID-19 pandemic, oncology nurses across the world were required to rapidly change to a telehealth service and adapt to provide safe and effective care to people living with cancer. 13 Rapid decisions were made, which included developing criteria for in-person versus remote care and developing equitable platforms for telehealth. Noteworthy, most decisions were made with limited guidelines or evidence for practice related to the pandemic. 13 Oncology nurses observed that telehealth may provide both a means for patients to be treated appropriately in their home environment without having to travel long distances for consultation, affording a timely solution to discuss side effects, interventions, and possible treatment additions and/or changes. 88 However, a barrier for oncology nurses who are involved in the provision of telehealth services includes the inability to perform a physical assessment (e.g auscultation) of the patient. This limitation, however, can be overcome using local healthcare professionals, who must ensure clear communication both

written and verbal back to the team.

Fundamental to the success of telehealth delivery is reliant on the patient being able to use the technology appropriately. 22 Other issues can include, and are not limited to, data speeds impacting and interrupting consultations, poor quality or low-resolution cameras which might be problematic in identifying physical ailments which require nursing assessment. 25 Moving forward into the pandemic and beyond, these issues may cause a real barrier to the safe delivery of cancer services and have the potential to delay urgent medical life-saving interventions and therefore, requires careful consideration.

Over the course of the COVID-19 pandemic oncology nurses globally have demonstrated their continued ability to be effective leaders. 13 Transformational nursing leadership requires the ability to think critically, provide timely evidence based actions and solutions to service delivery and advocacy across all settings and domains of oncology practice. 89 Nurses have been at the forefront of designing and delivering rapid changes, including telehealth within oncology services over the course of this pandemic. 13 Internationally, oncology nurses have navigated different complexities, such as: reducing on treatment patient volume, maintaining the safety of patients and staff, managing out-and-in patient clinic flow, delivering modified treatment protocols, transitioning telehealth models of service and delivering organisational strategy through clear communication.

The clinical telehealth response to the COVID-19 pandemic has been rapid and is continually evolving in oncology care. Evidence has identified that telehealth in oncology can be used across the interdisciplinary team to enable people to navigate the health system and access routine care during an infectious outbreak. The regular use of telehealth in cancer care may lead to more effective and sustainable models of care. However, the benefits and limitations of this model of service delivery needs to be carefully considered and appropriate training and education provided for all healthcare professionals and patients.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group

World Health Organisation. WHO Coronavirus Disease (COVID-19) Dashboard

A Literature Systematic Review with Meta-Analysis of Symptoms Prevalence in Covid-19: the Relevance of Olfactory Symptoms in Infection Not Requiring Hospitalization. Current treatment options in neurology

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. The Cochrane database of systematic reviews

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan

Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid

Mental health and the Covid-19 pandemic

Oncology nursing during a pandemic: critical reflections in the context of COVID-19

Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis

Tele-oncology in the COVID-19 Era: The Way Forward? Trends Cancer

Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic? European urology

Implementing Telemedicine in Response to the COVID-19 Pandemic

ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer

Accelerated importance of eHealth literacy in the COVID-19 outbreak and beyond

Internet and eHealth service usage: a survey among cancer patients and their relatives

The impact of cancer information online on cancer fatalism: education and eHealth literacy as moderators

eHealth literacy: essential skills for consumer health in a networked world

Navigating the digital divide: a systematic review of eHealth literacy in underserved populations in the United States. Informatics for Health and Social Care

Mobile health application and e-health literacy: opportunities and concerns for cancer patients and caregivers

Evaluating barriers to adopting telemedicine worldwide: A systematic review

Health literacy and health information technology adoption: the potential for a new digital divide

eHealth literacy and partner involvement in treatment decision making for men with newly diagnosed localized prostate cancer

Ready for eHealth? Health professionals' acceptance and adoption of eHealth interventions in inpatient routine care

eHEALS: the eHealth literacy scale

Predictors of high eHealth literacy in primary lung cancer survivors

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19

Mapping oncology services in regional and rural Australia

Medical oncology clinics through videoconferencing: an acceptable telehealth model for rural patients and health workers

The role of telehealth during COVID-19 outbreak: A systematic review based on current evidence

Patients' experiences of telehealth in palliative home care: scoping review

EC7CA25852E00223AFE/$File/COVID-19%20Bulk-billed%20MBS%20telehealth%20Services%20-%20Overarching%20200720.pdf

Virtual multidisciplinary team meetings in the age of COVID-19: an effective and pragmatic alternative. Quantitative imaging in medicine and surgery

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group

Student placement adaptability during COVID-19: Lessons learnt in 2020

Positive Clinical Outcomes Are Synergistic With Positive Educational Outcomes When Using Telehealth Consulting in General Practice: A Mixed-Methods Study

Telehealth in Psychiatric Nursing Education: Lessons From the Field

Telehealth: preparing advanced practice nurses to address healthcare needs in rural and underserved populations

Medical students represent a valuable resource in facilitating telehealth for the under-served

Defining a set of common interprofessional learning competencies for health profession students

Interprofessional education in allied health: a systematic review

COVID-19 and telehealth, education, and research adaptations

The Virtual Microscope

Virtual microscopy: high resolution digital photomicrography as a tool for light microscopy simulation

Digital light microscopy: prerequisite for optimum contrast enhancement and increase of resolution

Digital pathology in clinical use: where are we now and what is holding us back?

New Trends of Emerging Technologies in Digital Pathology

Implementation of large-scale routine diagnostics using whole slide imaging in Sweden: Digital pathology experiences 2006-2013

Digital pathology access and usage in the UK: results from a national survey on behalf of the National Cancer Research Institute's CM-Path initiative

Image analysis and machine learning in digital pathology: Challenges and opportunities

Validation of a digital pathology system including remote review during the COVID-19 pandemic

Improving pathology and laboratory medicine in lowincome and middle-income countries: roadmap to solutions

Complete routine remote digital pathology services

Being fully digital: perspective of a Dutch academic pathology laboratory

Digital pathology: Attitudes and practices in the Canadian pathology community

Validation of a whole-slide image-based teleconsultation network

Telehealth for musculoskeletal physiotherapy

Physiotherapy With Telerehabilitation in Patients With Complicated Postoperative Recovery After Esophageal Cancer Surgery: Feasibility Study

A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study

Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors

Nutrition and physical activity guidelines for cancer survivors

Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise

American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Medicine and science in sports and exercise

Telephone, print, and Webbased interventions for physical activity, diet, and weight control among cancer survivors: a systematic review

Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review

An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis

A randomized trial of a telephone-delivered exercise intervention for non-urban dwelling women newly diagnosed with breast cancer: exercise for health

Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer

Healthy Living after Cancer: a dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors

Exercise During Chemotherapy for Ovarian Cancer (Echo): Study Design Features and Outcomes of a Cancer Australia and Cancer Council Australia Funded Randomised, Controlled Trial

The Exercise and Sports Science Australia position statement: Exercise medicine in cancer management

Keeping Patients With Cancer Exercising in the Age of COVID-19

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Effects of exercise training and follow-up calls at home on physical activity and quality of life after a mastectomy

Fit4SurgeryTV At-home Prehabilitation for Frail Older Patients Planned for Colorectal Cancer Surgery: A Pilot Study. American journal of physical medicine & rehabilitation

Effect of a 12-Week Online Walking Intervention on Health and Quality of Life in Cancer Survivors: A Quasi-Randomized Controlled Trial

Efficacy of Mobile Health Care Application and Wearable Device in Improvement of Physical Performance in Colorectal Cancer Patients Undergoing Chemotherapy

Pilot and Feasibility Test of a Mobile Health-Supported Behavioral Counseling Intervention for Weight Management Among Breast Cancer Survivors

Soup cans, brooms, and Zoom:' Rapid conversion of a cancer survivorship program to telehealth during COVID-19

Accelerating the delivery of cancer care at home during the Covid-19 pandemic. NEJM Catalyst Innovations in Care Delivery

Leading wherever and whenever: Ensuring oncology nurses are future ready